Platinum Investment Management LTD Cytokinetics Inc Transaction History

Platinum Investment Management LTD

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 12, 2024	SELL	$47.86 - $75.05 $78,873 - $123,682	-1,648 Reduced 10.22%	14,478 $784,000
Q1 2024 May 13, 2024	SELL	$63.75 - $108.06 $192,015 - $325,476	-3,012 Reduced 15.74%	16,126 $1.13 Million
Q4 2023 Feb 13, 2024	BUY	$26.88 - $83.49 $514,429 - $1.6 Million	19,138 New	19,138 $1.6 Million

397

122M

3.46M

1.86M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.28B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

Stay updated on Platinum Investment Management LTD with notifications on news.